Overview

Combination Medications vs. Patch Alone for Medically-Ill Smokers

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness
Phase:
Phase 4
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborators:
Robert Wood Johnson Foundation
Rutgers Cancer Institute of New Jersey
Treatments:
Bupropion
Nicotine